The Association of Lipoprotein(A) and Coronary Artery Calcium in Primary Prevention Patients-Data from the STAR-Lp(A) Study

STAR-Lp(A) 研究的数据表明,脂蛋白(A)与冠状动脉钙化在初级预防患者中具有相关性。

阅读:1

Abstract

Background: Available studies have shown a correlation between higher lipoprotein(a) (Lp(a) levels and atherosclerotic diseases. We aimed to evaluate the association between Lp(a) and coronary artery calcification CAC Score among patients referred to outpatient cardiology clinics based on the data from the STAR-Lp(a) study. Methods: The study included consecutive patients referred to two outpatient cardiology clinics. The present analysis included primary prevention patients without atherosclerotic cardiovascular disease who underwent coronary computed tomographic angiography (CCTA). Results: We analyzed 528 patients (median age 68 years, 179 men, 349 women). Overall, 73.9% had Lp(a) < 30 mg/dL, 7.6% had 30-50 mg/dL, and 18.5% ≥ 50 mg/dL. The median coronary artery calcium (CAC) score was 23.5 (IQR 0.0-208.0), with 0 (0.0-40.0) in patients < 65 years and 58 (0.0-357.0) in those ≥65 years. In correlation analyses, Lp(a) was weakly associated with CAC (ρ = 0.11, p-FDR [false discovery rate] = 0.027), with stronger associations in men (ρ = 0.16, p-FDR = 0.011) and patients ≥ 65 years (ρ = 0.17, p-FDR = 0.011). No consistent associations were observed in younger patients or women. In multivariable ordinal logistic regression, age, male sex, smoking, and statin therapy were independent predictors of CAC severity, whereas Lp(a) was not. Similarly, Lp(a) did not predict CAC score of zero. These findings suggest Lp(a) relates to CAC in older men, but not independently of established risk factors. Conclusions: This study found a weak association between Lp(a) levels and coronary artery calcification, evident mainly in patients aged ≥65 years.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。